nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CYP2D6—Hydroxyurea—head and neck cancer	0.258	0.449	CbGbCtD
Cinacalcet—CYP1A2—Fluorouracil—head and neck cancer	0.12	0.208	CbGbCtD
Cinacalcet—CYP2D6—Vinblastine—head and neck cancer	0.0915	0.159	CbGbCtD
Cinacalcet—CASR—parathyroid gland—head and neck cancer	0.0785	0.549	CbGeAlD
Cinacalcet—CYP3A4—Vinblastine—head and neck cancer	0.0582	0.101	CbGbCtD
Cinacalcet—CYP3A4—Docetaxel—head and neck cancer	0.0479	0.0832	CbGbCtD
Cinacalcet—CASR—neck—head and neck cancer	0.0238	0.166	CbGeAlD
Cinacalcet—Metastatic neoplasm—Hydroxyurea—head and neck cancer	0.0219	0.136	CcSEcCtD
Cinacalcet—CASR—connective tissue—head and neck cancer	0.017	0.119	CbGeAlD
Cinacalcet—Metastatic neoplasm—Docetaxel—head and neck cancer	0.0114	0.0708	CcSEcCtD
Cinacalcet—CASR—thyroid gland—head and neck cancer	0.0113	0.0792	CbGeAlD
Cinacalcet—CASR—head—head and neck cancer	0.01	0.0702	CbGeAlD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—CDH1—head and neck cancer	0.00921	0.0795	CbGpPWpGaD
Cinacalcet—Multi-organ failure—Docetaxel—head and neck cancer	0.0067	0.0417	CcSEcCtD
Cinacalcet—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.00567	0.049	CbGpPWpGaD
Cinacalcet—CASR—G alpha (q) signalling events—KISS1—head and neck cancer	0.00558	0.0482	CbGpPWpGaD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—EGFR—head and neck cancer	0.00539	0.0465	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.00499	0.0431	CbGpPWpGaD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—PIK3CA—head and neck cancer	0.00467	0.0403	CbGpPWpGaD
Cinacalcet—CASR—G alpha (q) signalling events—GRP—head and neck cancer	0.0046	0.0397	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.00411	0.0355	CbGpPWpGaD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—AKT1—head and neck cancer	0.00382	0.0329	CbGpPWpGaD
Cinacalcet—Floctafenine—PTGS2—head and neck cancer	0.00323	0.744	CrCbGaD
Cinacalcet—CASR—GPCR ligand binding—KISS1—head and neck cancer	0.00281	0.0243	CbGpPWpGaD
Cinacalcet—Depression—Vinblastine—head and neck cancer	0.00257	0.016	CcSEcCtD
Cinacalcet—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00248	0.0214	CbGpPWpGaD
Cinacalcet—Bone disorder—Docetaxel—head and neck cancer	0.00242	0.015	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—GRP—head and neck cancer	0.00232	0.02	CbGpPWpGaD
Cinacalcet—Cardiac failure—Fluorouracil—head and neck cancer	0.00225	0.014	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.0022	0.0137	CcSEcCtD
Cinacalcet—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00211	0.0182	CbGpPWpGaD
Cinacalcet—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00192	0.0166	CbGpPWpGaD
Cinacalcet—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00191	0.0165	CbGpPWpGaD
Cinacalcet—Anaemia—Vinblastine—head and neck cancer	0.00186	0.0116	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00176	0.011	CcSEcCtD
Cinacalcet—Convulsion—Vinblastine—head and neck cancer	0.00175	0.0109	CcSEcCtD
Cinacalcet—Hypertension—Vinblastine—head and neck cancer	0.00174	0.0108	CcSEcCtD
Cinacalcet—Anaemia—Hydroxyurea—head and neck cancer	0.0017	0.0106	CcSEcCtD
Cinacalcet—Cardiac failure—Docetaxel—head and neck cancer	0.00162	0.0101	CcSEcCtD
Cinacalcet—Convulsion—Hydroxyurea—head and neck cancer	0.00159	0.0099	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—KISS1—head and neck cancer	0.00159	0.0137	CbGpPWpGaD
Cinacalcet—Pain in extremity—Docetaxel—head and neck cancer	0.00159	0.00986	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00159	0.00986	CcSEcCtD
Cinacalcet—Anorexia—Vinblastine—head and neck cancer	0.00157	0.00975	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00155	0.00966	CcSEcCtD
Cinacalcet—Infection—Hydroxyurea—head and neck cancer	0.00149	0.00927	CcSEcCtD
Cinacalcet—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00148	0.0128	CbGpPWpGaD
Cinacalcet—Paraesthesia—Vinblastine—head and neck cancer	0.00148	0.00918	CcSEcCtD
Cinacalcet—Dehydration—Docetaxel—head and neck cancer	0.00147	0.00917	CcSEcCtD
Cinacalcet—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00147	0.00915	CcSEcCtD
Cinacalcet—Skin disorder—Hydroxyurea—head and neck cancer	0.00146	0.00906	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—KISS1—head and neck cancer	0.00144	0.0125	CbGpPWpGaD
Cinacalcet—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.00143	0.0124	CbGpPWpGaD
Cinacalcet—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00143	0.0123	CbGpPWpGaD
Cinacalcet—Anorexia—Hydroxyurea—head and neck cancer	0.00143	0.00889	CcSEcCtD
Cinacalcet—Decreased appetite—Vinblastine—head and neck cancer	0.00143	0.00889	CcSEcCtD
Cinacalcet—Cramp muscle—Docetaxel—head and neck cancer	0.00143	0.00888	CcSEcCtD
Cinacalcet—Constipation—Vinblastine—head and neck cancer	0.00141	0.00875	CcSEcCtD
Cinacalcet—CYP1A2—thyroid gland—head and neck cancer	0.00141	0.00983	CbGeAlD
Cinacalcet—Arrhythmia—Fluorouracil—head and neck cancer	0.00136	0.00844	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00135	0.00836	CcSEcCtD
Cinacalcet—Dyspnoea—Hydroxyurea—head and neck cancer	0.00134	0.00831	CcSEcCtD
Cinacalcet—Dyspepsia—Hydroxyurea—head and neck cancer	0.00132	0.00821	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—GRP—head and neck cancer	0.00131	0.0113	CbGpPWpGaD
Cinacalcet—Decreased appetite—Hydroxyurea—head and neck cancer	0.0013	0.00811	CcSEcCtD
Cinacalcet—Abdominal pain—Vinblastine—head and neck cancer	0.0013	0.00808	CcSEcCtD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.0013	0.0112	CbGpPWpGaD
Cinacalcet—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.0013	0.00805	CcSEcCtD
Cinacalcet—Fatigue—Hydroxyurea—head and neck cancer	0.00129	0.00804	CcSEcCtD
Cinacalcet—Constipation—Hydroxyurea—head and neck cancer	0.00128	0.00798	CcSEcCtD
Cinacalcet—Anaemia—Fluorouracil—head and neck cancer	0.00122	0.0076	CcSEcCtD
Cinacalcet—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00121	0.0105	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Vinblastine—head and neck cancer	0.00121	0.00753	CcSEcCtD
Cinacalcet—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.0012	0.0103	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—GRP—head and neck cancer	0.00119	0.0103	CbGpPWpGaD
Cinacalcet—Body temperature increased—Hydroxyurea—head and neck cancer	0.00119	0.00737	CcSEcCtD
Cinacalcet—Asthenia—Vinblastine—head and neck cancer	0.00118	0.00734	CcSEcCtD
Cinacalcet—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.00116	0.01	CbGpPWpGaD
Cinacalcet—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00115	0.00993	CbGpPWpGaD
Cinacalcet—Convulsion—Fluorouracil—head and neck cancer	0.00115	0.00713	CcSEcCtD
Cinacalcet—Chest pain—Fluorouracil—head and neck cancer	0.00113	0.007	CcSEcCtD
Cinacalcet—Myalgia—Fluorouracil—head and neck cancer	0.00113	0.007	CcSEcCtD
Cinacalcet—Diarrhoea—Vinblastine—head and neck cancer	0.00113	0.007	CcSEcCtD
Cinacalcet—Propranolol—CYP1A1—head and neck cancer	0.00111	0.256	CrCbGaD
Cinacalcet—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00111	0.00687	CcSEcCtD
Cinacalcet—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.0011	0.00952	CbGpPWpGaD
Cinacalcet—Dizziness—Vinblastine—head and neck cancer	0.00109	0.00676	CcSEcCtD
Cinacalcet—Oedema peripheral—Docetaxel—head and neck cancer	0.00108	0.00672	CcSEcCtD
Cinacalcet—Asthenia—Hydroxyurea—head and neck cancer	0.00108	0.00669	CcSEcCtD
Cinacalcet—Infection—Fluorouracil—head and neck cancer	0.00107	0.00667	CcSEcCtD
Cinacalcet—Nervous system disorder—Fluorouracil—head and neck cancer	0.00106	0.00658	CcSEcCtD
Cinacalcet—Vomiting—Vinblastine—head and neck cancer	0.00105	0.0065	CcSEcCtD
Cinacalcet—Headache—Vinblastine—head and neck cancer	0.00103	0.00641	CcSEcCtD
Cinacalcet—Anorexia—Fluorouracil—head and neck cancer	0.00103	0.0064	CcSEcCtD
Cinacalcet—Diarrhoea—Hydroxyurea—head and neck cancer	0.00103	0.00638	CcSEcCtD
Cinacalcet—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.00101	0.00875	CbGpPWpGaD
Cinacalcet—Hypotension—Fluorouracil—head and neck cancer	0.00101	0.00627	CcSEcCtD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.001	0.00863	CbGpPWpGaD
Cinacalcet—Dizziness—Hydroxyurea—head and neck cancer	0.000992	0.00617	CcSEcCtD
Cinacalcet—Immune system disorder—Docetaxel—head and neck cancer	0.000991	0.00616	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000984	0.00612	CcSEcCtD
Cinacalcet—Arrhythmia—Docetaxel—head and neck cancer	0.00098	0.00609	CcSEcCtD
Cinacalcet—Nausea—Vinblastine—head and neck cancer	0.000977	0.00607	CcSEcCtD
Cinacalcet—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000975	0.00842	CbGpPWpGaD
Cinacalcet—Paraesthesia—Fluorouracil—head and neck cancer	0.00097	0.00603	CcSEcCtD
Cinacalcet—Dyspnoea—Fluorouracil—head and neck cancer	0.000963	0.00598	CcSEcCtD
Cinacalcet—Malnutrition—Docetaxel—head and neck cancer	0.000955	0.00594	CcSEcCtD
Cinacalcet—Vomiting—Hydroxyurea—head and neck cancer	0.000954	0.00593	CcSEcCtD
Cinacalcet—Dyspepsia—Fluorouracil—head and neck cancer	0.000951	0.00591	CcSEcCtD
Cinacalcet—Rash—Hydroxyurea—head and neck cancer	0.000946	0.00588	CcSEcCtD
Cinacalcet—Dermatitis—Hydroxyurea—head and neck cancer	0.000945	0.00587	CcSEcCtD
Cinacalcet—Headache—Hydroxyurea—head and neck cancer	0.00094	0.00584	CcSEcCtD
Cinacalcet—Decreased appetite—Fluorouracil—head and neck cancer	0.000939	0.00584	CcSEcCtD
Cinacalcet—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000936	0.00807	CbGpPWpGaD
Cinacalcet—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000932	0.0058	CcSEcCtD
Cinacalcet—Muscle spasms—Docetaxel—head and neck cancer	0.000918	0.00571	CcSEcCtD
Cinacalcet—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000898	0.00775	CbGpPWpGaD
Cinacalcet—Nausea—Hydroxyurea—head and neck cancer	0.000891	0.00554	CcSEcCtD
Cinacalcet—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000889	0.00767	CbGpPWpGaD
Cinacalcet—CYP2D6—head—head and neck cancer	0.000888	0.00621	CbGeAlD
Cinacalcet—Anaemia—Docetaxel—head and neck cancer	0.000883	0.00549	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.00088	0.0076	CbGpPWpGaD
Cinacalcet—Urticaria—Fluorouracil—head and neck cancer	0.000858	0.00533	CcSEcCtD
Cinacalcet—Body temperature increased—Fluorouracil—head and neck cancer	0.000854	0.00531	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—KISS1—head and neck cancer	0.000853	0.00736	CbGpPWpGaD
Cinacalcet—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000851	0.00735	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000838	0.00723	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000838	0.00723	CbGpPWpGaD
Cinacalcet—Cough—Docetaxel—head and neck cancer	0.000833	0.00518	CcSEcCtD
Cinacalcet—Convulsion—Docetaxel—head and neck cancer	0.000827	0.00514	CcSEcCtD
Cinacalcet—Hypertension—Docetaxel—head and neck cancer	0.000824	0.00513	CcSEcCtD
Cinacalcet—Myalgia—Docetaxel—head and neck cancer	0.000813	0.00505	CcSEcCtD
Cinacalcet—Arthralgia—Docetaxel—head and neck cancer	0.000813	0.00505	CcSEcCtD
Cinacalcet—Chest pain—Docetaxel—head and neck cancer	0.000813	0.00505	CcSEcCtD
Cinacalcet—CASR—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000813	0.00701	CbGpPWpGaD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000807	0.00502	CcSEcCtD
Cinacalcet—Hypersensitivity—Fluorouracil—head and neck cancer	0.000796	0.00495	CcSEcCtD
Cinacalcet—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000783	0.00675	CbGpPWpGaD
Cinacalcet—Infection—Docetaxel—head and neck cancer	0.000774	0.00481	CcSEcCtD
Cinacalcet—Nervous system disorder—Docetaxel—head and neck cancer	0.000764	0.00475	CcSEcCtD
Cinacalcet—Pruritus—Fluorouracil—head and neck cancer	0.000764	0.00475	CcSEcCtD
Cinacalcet—Skin disorder—Docetaxel—head and neck cancer	0.000757	0.00471	CcSEcCtD
Cinacalcet—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000753	0.0065	CbGpPWpGaD
Cinacalcet—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000753	0.00649	CbGpPWpGaD
Cinacalcet—Anorexia—Docetaxel—head and neck cancer	0.000743	0.00462	CcSEcCtD
Cinacalcet—Diarrhoea—Fluorouracil—head and neck cancer	0.000739	0.00459	CcSEcCtD
Cinacalcet—Hypotension—Docetaxel—head and neck cancer	0.000728	0.00453	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000727	0.00627	CbGpPWpGaD
Cinacalcet—Dizziness—Fluorouracil—head and neck cancer	0.000714	0.00444	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00071	0.00441	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—GRP—head and neck cancer	0.000703	0.00606	CbGpPWpGaD
Cinacalcet—Paraesthesia—Docetaxel—head and neck cancer	0.0007	0.00435	CcSEcCtD
Cinacalcet—Dyspnoea—Docetaxel—head and neck cancer	0.000695	0.00432	CcSEcCtD
Cinacalcet—Vomiting—Fluorouracil—head and neck cancer	0.000687	0.00427	CcSEcCtD
Cinacalcet—Dyspepsia—Docetaxel—head and neck cancer	0.000686	0.00426	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—STAT6—head and neck cancer	0.000682	0.00589	CbGpPWpGaD
Cinacalcet—Rash—Fluorouracil—head and neck cancer	0.000681	0.00423	CcSEcCtD
Cinacalcet—Dermatitis—Fluorouracil—head and neck cancer	0.00068	0.00423	CcSEcCtD
Cinacalcet—Decreased appetite—Docetaxel—head and neck cancer	0.000678	0.00421	CcSEcCtD
Cinacalcet—Headache—Fluorouracil—head and neck cancer	0.000676	0.00421	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000673	0.00418	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000673	0.0058	CbGpPWpGaD
Cinacalcet—Fatigue—Docetaxel—head and neck cancer	0.000672	0.00418	CcSEcCtD
Cinacalcet—Constipation—Docetaxel—head and neck cancer	0.000666	0.00414	CcSEcCtD
Cinacalcet—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000664	0.00573	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000662	0.00571	CbGpPWpGaD
Cinacalcet—Nausea—Fluorouracil—head and neck cancer	0.000641	0.00399	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000637	0.00396	CcSEcCtD
Cinacalcet—Body temperature increased—Docetaxel—head and neck cancer	0.000616	0.00383	CcSEcCtD
Cinacalcet—Abdominal pain—Docetaxel—head and neck cancer	0.000616	0.00383	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—YAP1—head and neck cancer	0.000604	0.00521	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Docetaxel—head and neck cancer	0.000574	0.00357	CcSEcCtD
Cinacalcet—Asthenia—Docetaxel—head and neck cancer	0.000559	0.00348	CcSEcCtD
Cinacalcet—Pruritus—Docetaxel—head and neck cancer	0.000551	0.00343	CcSEcCtD
Cinacalcet—Diarrhoea—Docetaxel—head and neck cancer	0.000533	0.00332	CcSEcCtD
Cinacalcet—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000521	0.00449	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000521	0.00449	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000521	0.00449	CbGpPWpGaD
Cinacalcet—Dizziness—Docetaxel—head and neck cancer	0.000515	0.0032	CcSEcCtD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000497	0.00429	CbGpPWpGaD
Cinacalcet—Vomiting—Docetaxel—head and neck cancer	0.000496	0.00308	CcSEcCtD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000492	0.00425	CbGpPWpGaD
Cinacalcet—Rash—Docetaxel—head and neck cancer	0.000491	0.00305	CcSEcCtD
Cinacalcet—Dermatitis—Docetaxel—head and neck cancer	0.000491	0.00305	CcSEcCtD
Cinacalcet—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000491	0.00423	CbGpPWpGaD
Cinacalcet—Headache—Docetaxel—head and neck cancer	0.000488	0.00304	CcSEcCtD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000487	0.0042	CbGpPWpGaD
Cinacalcet—Nausea—Docetaxel—head and neck cancer	0.000463	0.00288	CcSEcCtD
Cinacalcet—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000457	0.00394	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000451	0.00389	CbGpPWpGaD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000421	0.00363	CbGpPWpGaD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000416	0.00359	CbGpPWpGaD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000403	0.00348	CbGpPWpGaD
Cinacalcet—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000402	0.00347	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000387	0.00334	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000382	0.0033	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—IL2—head and neck cancer	0.000349	0.00301	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000341	0.00295	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000327	0.00282	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000325	0.0028	CbGpPWpGaD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000321	0.00277	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL2—head and neck cancer	0.000317	0.00273	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.00031	0.00267	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000299	0.00258	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000295	0.00254	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00029	0.0025	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000287	0.00248	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NOTCH1—head and neck cancer	0.000272	0.00235	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000263	0.00227	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—MAPK3—head and neck cancer	0.000255	0.0022	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000244	0.00211	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—MAPK1—head and neck cancer	0.000242	0.00209	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—EGFR—head and neck cancer	0.000242	0.00209	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000232	0.002	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000226	0.00195	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000223	0.00192	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.00022	0.00189	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.00022	0.00189	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.00022	0.00189	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000214	0.00185	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000211	0.00182	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PIK3CA—head and neck cancer	0.00021	0.00182	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—HRAS—head and neck cancer	0.000195	0.00168	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000191	0.00165	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—AKT1—head and neck cancer	0.000189	0.00163	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000189	0.00163	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—UROD—head and neck cancer	0.000188	0.00162	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL2—head and neck cancer	0.000187	0.00162	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCND1—head and neck cancer	0.000182	0.00157	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.000181	0.00156	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000179	0.00154	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000176	0.00152	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PTEN—head and neck cancer	0.000176	0.00152	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—AKT1—head and neck cancer	0.000172	0.00148	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—UROD—head and neck cancer	0.000159	0.00138	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—VEGFA—head and neck cancer	0.000159	0.00137	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—STAT3—head and neck cancer	0.000158	0.00136	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MAPK3—head and neck cancer	0.000151	0.0013	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000148	0.00127	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000146	0.00126	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MAPK1—head and neck cancer	0.000143	0.00124	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EGFR—head and neck cancer	0.000143	0.00124	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.00014	0.00121	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000138	0.00119	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CA—head and neck cancer	0.000124	0.00107	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000124	0.00107	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—UROD—head and neck cancer	0.000123	0.00106	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TP53—head and neck cancer	0.00012	0.00104	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—HRAS—head and neck cancer	0.000115	0.000992	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—AKT1—head and neck cancer	0.000102	0.000876	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NAT2—head and neck cancer	7.82e-05	0.000675	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.03e-05	0.000607	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.96e-05	0.000601	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—DPYD—head and neck cancer	6.86e-05	0.000592	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NAT2—head and neck cancer	6.62e-05	0.000571	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—YAP1—head and neck cancer	6.51e-05	0.000561	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—DPYD—head and neck cancer	5.81e-05	0.000501	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—YAP1—head and neck cancer	5.51e-05	0.000476	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NAT2—head and neck cancer	5.11e-05	0.000441	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—DPYD—head and neck cancer	4.48e-05	0.000387	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—YAP1—head and neck cancer	4.25e-05	0.000367	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.14e-05	0.000357	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TYMS—head and neck cancer	3.91e-05	0.000337	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTM1—head and neck cancer	3.86e-05	0.000333	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GPX1—head and neck cancer	3.7e-05	0.000319	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP1A1—head and neck cancer	3.66e-05	0.000316	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.61e-05	0.000312	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TYMS—head and neck cancer	3.31e-05	0.000286	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTM1—head and neck cancer	3.27e-05	0.000282	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GPX1—head and neck cancer	3.13e-05	0.00027	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP1A1—head and neck cancer	3.1e-05	0.000268	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TYMS—head and neck cancer	2.55e-05	0.00022	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.55e-05	0.00022	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.52e-05	0.000218	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GPX1—head and neck cancer	2.42e-05	0.000209	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.39e-05	0.000207	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTGS2—head and neck cancer	2.18e-05	0.000188	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTEN—head and neck cancer	1.9e-05	0.000164	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.84e-05	0.000159	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTEN—head and neck cancer	1.61e-05	0.000139	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.42e-05	0.000123	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.34e-05	0.000116	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTEN—head and neck cancer	1.24e-05	0.000107	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.13e-05	9.79e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—AKT1—head and neck cancer	1.09e-05	9.44e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—AKT1—head and neck cancer	9.27e-06	8e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CA—head and neck cancer	8.76e-06	7.56e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AKT1—head and neck cancer	7.15e-06	6.17e-05	CbGpPWpGaD
